Bedier, H. et al. 2023. Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19. European Journal of Case Reports in Internal Medicine. 10, 12 (Nov. 2023). DOI:https://doi.org/10.12890/2023_004098.